Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-10

Clinical Trial Update: Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of repaglinide, metformin, and a repaglinide/metformin combination tablet in fed healthy volunteers. The update presents single-do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Repaglinide (Repaglinide)
  • Repaglinide/metformin (repaglinide/metformin)
  • metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED